Dennis O'Neill is currently the CEO of O’Neill Capital Advisors, President and Board Member of Biomedican, Bio-Kai and ActinexRX. He has over 30 years experience as an Investment Banker. He helped start two of the largest regional Investments banks in Chicago then went on to Managing Director for Softbank Investments/ E2Capital office in Chicago and raised over 2 billion dollars in capital for early-stage companies to date. Mr. O'Neill has a significant amount of experience and success in Sales, Marketing, Financial Media/Journalist, Business Development and Institutional Capital Raises. He is an expert and thought leader on Venture Capital, Private Equity, Biotech, Cannabis Therapeutics, Blockchain/Crypto and Smallcap stocks and has spoken at over 75 conferences around the world.
Dennis O'Neill, O'Neill Capital Advisors
What does O’Neill Capital Advisors Do?
O'Neill Capital Advisors helps companies raise institutional capital via SPACs, Security Token Offerings, or Venture Capital. Our private network currently has over 40,000 Investors and consists of Family Offices, Ultra High Net worth Individuals, Hedge Funds, Money Managers, Venture Capital and Private Equity/Venture Capital funds, Crypto Funds, and Sovereign Wealth Funds. O'Neill Capital Advisors' reputation and relationships allow the company's project to be taken very seriously by Institutional Investors. Our experience, reputation and relationships provide 3rd party credibility and validation for highly sophisticated investors. The network is global, with significant strength in Europe, Asia, and UAE.
Why are you opening an office in Singapore?
The Company is now opening an office in Singapore, taking advantage of the economic growth throughout S.E. Asia. Singapore is known as the gateway to Asia, a country with a stable economy, great government, and a strong legal system. It also has the largest concentration of Family Offices in the world. These qualities are some of the reasons O’Neill Capital Advisors opened an office there. The RCEP, known as the Regional Comprehensive Economic Partnership, is a “FREE-Trade” zone with 15 countries; Singapore’s membership provides businesses tariff-free with access to 1/3 of the world’s population within these growing economies. The problem we are solving is smaller businesses have no real Asian strategy; the answer we set forth is to help those entities get a foothold in Asia. We believe O’Neill Capital Advisors' presence in Singapore can assist US and SE Asian entities who would like to expand operations in these areas. In the following months, O’Neill Capital Advisors will assist Asian businesses with public listings in the USA through SPACs – Special Purpose Acquisitions Companies.
Can Early Stage US-based companies benefit from the Asian Markets?
We help US-based early-stage companies set up in Singapore that positions them strategically to take advantage of the significant amount of Government support. Grants, Matching investment funds and many government associations help early-stage companies access capital for R&D, Sales and Marketing and ultimately expansion into the region, leveraging the RCEP/Largest Free Trade Zone in the world. These are amongst the fastest-growing markets in the world and the companies that can position themselves to take advantage of these markets will be well positioned for long-term success.
